HANALL BIOPHARMA CO.,LTD Stock Price & Chart

KRX: 009420 · 한올바이오파마 · KOSPI

₩50,100 ₩2,500 (-4.75%)at close · September 11, 2026
73,00028,05050,100Aug 20, 25Nov 26Mar 06Jun 10Sep 11, 26

HANALL BIOPHARMA CO.,LTD (한올바이오파마, KRX: 009420) last closed at ₩50,100 on September 11, 2026, a -4.75% move on the day. Over the trailing 52 weeks the stock has traded between ₩28,950 and ₩73,000, a +72.16% change over the past year. Figures are end-of-day closing prices from the Korea Exchange.

Last close₩50,100
Day change-4.75%
52-week high₩73,000
52-week low₩28,950

Key Fundamentals

FY 2026.06
Market cap₩2.62T
P/E (PER)-472.64
P/B (PBR)15.73
EPS₩-106
BPS₩3,184
ROE-15.68%
Debt ratio48.81%
Rev. growth9.73%

P/E, P/B and market cap are computed from the latest close; EPS, BPS, ROE and debt ratio are the most recent reported figures (FY 2026.06) from the Korea Investment & Securities Open API. Informational only, not investment advice.

Analyst Consensus

6 ratings · last Aug 20, 2026
Buy6
Hold0
Sell0
Avg. target₩90,667
Upside+81.0%
High₩130,000
Low₩70,000
BrokerageRatingTargetDate
NH Investment & SecuritiesBuy₩98,000Aug 20, 2026
Kiwoom SecuritiesBuy₩80,000Aug 18, 2026
Hyundai Motor SecuritiesBuy₩93,000Jun 1, 2026
Shinhan SecuritiesBuy₩130,000May 29, 2026
Kyobo SecuritiesNot RatedMay 22, 2026
Daol Investment & SecuritiesBuy₩70,000May 21, 2026
IBK Investment & SecuritiesBuy₩73,000May 21, 2026
Samsung SecuritiesNot RatedApr 10, 2026

Latest published rating and 12-month target price per brokerage over the past 180 days, via the Korea Investment & Securities Open API. Each house is counted once at its most recent view; averages exclude unrated notes. This summarises what analysts have published — it is not a recommendation, and not investment advice.

Technical Snapshot

as of 2026-09-11
Weak BearishAlgorithmic summary of 6 standard indicators (net score -2). Describes current technical posture only — not a buy or sell recommendation.
  • ▼ Bearish20-day MAPrice below 57,735
  • ▼ Bearish60-day MAPrice below 54,966
  • ▼ Bearish120-day MAPrice below 53,168
  • ▲ BullishMA trend (20 vs 60)Short-term above mid-term
  • ▲ BullishRSI (14)RSI 28 — oversold
  • ▼ BearishMACD (12,26,9)MACD below signal
52-week position: 48% of rangeRSI(14): 285-day volume vs 20-day: -17%

Indicators are computed mechanically from end-of-day prices. They are provided for informational purposes only, are not investment advice or a recommendation, and past performance does not indicate future results.

No daily reports have covered HANALL BIOPHARMA CO.,LTD yet. New reports appear here automatically when the stock is featured.

← Back to all Korean stocks

Price history is sourced from the Korea Exchange via the Korea Investment & Securities Open API and updated after each trading session. This page is provided for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data may be delayed or contain errors — verify with an official source before trading.